- $312.40m
- $203.60m
- $92.39m
U.S. STOCKS ON THE MOVE-Gold miners, Weave Communications, Amylyx Pharmaceuticals
U.S. STOCKS ON THE MOVE-BioMarin Pharmaceutical, Home Depot, Klarna Group
Prenetics Global Ltd reports results for the quarter ended June 30 - Earnings Summary
U.S. STOCKS ON THE MOVE-EyePoint Inc, Amer Sports, Pliant Therapeutics
Prenetics rises on Q2 revenue jump
Prenetics Global Q2 revenue jumps on AI brand growth
Prenetics Global Ltd expected to post a loss of 71 cents a share - Earnings Preview
Brief: Prenetics’IM8 Secures $1 Bln Growth Financing From General Catalyst’S Customer Value Fund
Supplements maker Prenetics' Q1 revenue surges on IM8 growth, raises outlook
Brief: Prenetics Announces Jay Shetty As Im8 Global Ambassador And Shareholder In Multi-Year Partnership
Hong Kong's Prenetics Q1 revenue quadruples on IM8 growth
Brief: Prenetics Global Q1 Revenue USD 36 Million
Brief: Prenetics’ Im8 Named Exclusive Health Supplements Partner Of Inter Miami Cf In Multi-Year Partnership
Brief: Prenetics Global Ltd Files For Offering Of Up To 2.36 Million Class A Ordinary Shares By Selling Shareholders - SEC Filing
Brief: Prenetics Authorizes $40 Million Share Repurchase Program
Prenetics Global Q4 revenue surges 457%
Brief: Prenetics Reinforces Strategic Focus On Im8, Divests Europa Business For Up To $13 Million
Brief: Prenetics Provides Update On Voluntary Warrant Exchange Program
Brief: Prenetics Enters Into Warrant Exchange Agreements With Warrant Holders, Strengthening Capital Structure